Incruse Ellipta, einzeldosiertes Pulver zur Inhalation
7680650910015
CH-65091
Einzeldosiertes Pulver zur Inhalation
Associated product:
INCRUSE ELLIPTA pdr inh 55 mcg 30 dos
1 / 3
google
Article details
- Package size
- 30
- Selling units
- 30
- Measure
- Einzeldose(n)
- Galenic form
- Einzeldosiertes Pulver zur Inhalation
- Galenic group
- unbekannt
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
62.5 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
55.0 UG | Substance | Wirkstoff (Principe actif) |
Reimbursement information
Public price
CHF 54.10
Specialties list
Yes
Generic
No
SL addition date:
01/09/2015
Authorization holder
GlaxoSmithKline AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 65091
- Drug name
- Incruse Ellipta, einzeldosiertes Pulver zur Inhalation
- Galenic form
- PUINE
- ATC Code
- R03BB07
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 29/09/2014
- Authorization expiration date
- 31/12/9999
- IT Number
- 03.04.3.
- Domain
- Human medicine
Package details
- Description (FR)
- INCRUSE ELLIPTA pdr inh 55 mcg 30 dos
- Description (DE)
- INCRUSE ELLIPTA Inh Plv 55 mcg 30 Dos
- Market launch
- 29/09/2014
- Narcotic (BTM)
- No
Other package sizes (1)
INCRUSE ELLIPTA pdr inh 55 mcg 3 x 30 dos
3 x 30 EINZ
GTIN: 7680650910022